Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tributes have begun pouring in across the University of Oxford and the international neuroscience and psychology communities today in response to the news that Professor Glyn Humphreys passed away suddenly yesterday morning. Professor Humphreys was Watts Professor of Experimental Psychology and Head of the Department of Experimental Psychology at the University of Oxford. He was a leading light of cognitive neuropsychology and received the British Psychological Society Lifetime Achievement Award in 2015 in recognition of his exceptional contributions to the field of psychology.

Responding to the news, Professor Alastair Buchan, Head of the Medical Sciences Division, said in a statement this morning: ‘I speak for the whole Division when I say we are all affected by this extremely sad news. Glyn was so young and so full of life and vitality. Together with his wife and colleague Jane Riddoch they brought both wisdom and experience to both Experimental Psychology and the John Radcliffe Hospital. He is going to be terribly missed. Our thoughts are with his wife Jane and their family.’

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.